Barclays’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
DA
Barclays's PRTA Position: Q3 2026 in Review
Barclays increased its Prothena Corp (PRTA) stake by 70% in Q3 2026, buying an estimated $236K and bringing the position to 63,989 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #3421.
Barclays first reported a position in PRTA in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.18M in Q4 2023. 55 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.
- Barclays held 63,989 shares of Prothena Corp worth $536K as of Q3 2026.
- Barclays bought 26,366 Prothena Corp shares in Q3 2026, an estimated $236K.
- Prothena Corp made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3421 holding.
- Barclays first reported a position in Prothena Corp in Q2 2013 and has held it in 53 quarters since.
- Barclays's Prothena Corp position peaked at $5.18M in Q4 2023.
- 55 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.